Skip to main content

Table 3 Effect-size estimates of serum thyroid hormones with various stages of DKD

From: Association between thyroid hormones and diabetic kidney disease in Chinese adults

Significant risk factors

Low risk

Moderate risk

High risk

Very high risk

FT3 (+ 0.2 pg/mL)

Reference

0.87, 0.81 to 0.93, < 0.001

0.79, 0.74 to 0.85, < 0.001

0.56, 0.52 to 0.61, < 0.001

FT4 (+ 0.2 ng/dL)

Reference

1.20, 1.06 to 1.38, 0.005

1.04, 0.92 to 1.18, 0.491

0.82, 0.73 to 0.92, 0.001

TSH (+ 0.5 µIU/mL)

Reference

1.00, 0.99 to 1.00, 0.394

1.00, 0.99 to 1.00, 0.378

1.00, 1.00 to 1.01, 0.344

After balancing age, gender, hypertension, HbA1c, TC, TG and duration of diabetes

FT3 (+ 0.2 g/mL)

Reference

0.87, 0.70 to 0.87, 0.006

0.78, 0.70 to 0.87, < 0.001

0.63, 0.55 to 0.72, < 0.001

FT4 (+ 0.2 ng/dL)

Reference

1.24, 1.04 to 1.50, 0.015

1.09, 0.93 to 1.30, 0.277

0.93, 0.78 to 1.11, 0.418

TSH (+ 0.5 µIU/mL)

Reference

0.99, 0.97 to 1.02, 0.352

0.99, 0.96 to 1.01, 0.264

0.99, 0.98 to 1.01, 0.329

  1. Abbreviations: FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone. Data are expressed as odds ratio, 95% confidence interval, P value